What is CarePredict?
CarePredict operates at the intersection of artificial intelligence and geriatric care, providing a sophisticated ecosystem designed to detect health declines before they become acute. The company's flagship wearable, Tempo, utilizes machine learning to autonomously interpret daily activity patterns, offering caregivers actionable insights that facilitate timely interventions. By shifting the paradigm from reactive to predictive care, CarePredict has established itself as a vital partner for both professional care providers and family members seeking to improve the quality of life for seniors. Its market position is bolstered by a focus on non-intrusive monitoring, which preserves the dignity of the individual while ensuring safety and operational efficiency in senior living facilities.
How much funding has CarePredict raised?
CarePredict has raised a total of $44.5M across 6 funding rounds:
Private Equity
$1M
Private Equity
$2.5M
Debt
$150K
Debt
$364K
Series A
$38.5M
Private Equity
$2M
Private Equity (2015): $1M, investors not publicly disclosed
Private Equity (2016): $2.5M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Debt (2021): $364K featuring PPP
Series A (2023): $38.5M backed by Startup Health Ventures, Aspire Healthtech Partners, Las Olas VC, and Secocha Ventures
Private Equity (2026): $2M, investors not publicly disclosed
Key Investors in CarePredict
Las Olas VC
Las Olas Venture Capital is a venture capital firm that focuses on backing founders who are developing AI and software applications aimed at modernizing outdated business workflows.
Startup Health Ventures
A global organization and investment firm dedicated to supporting health moonshot entrepreneurs through a vast network of industry experts and resources.
Aspire Healthtech Partners
A specialized investment group focused on scaling high-impact technologies that improve clinical outcomes and operational efficiency within the healthcare sector.
What's next for CarePredict?
With the successful closure of this major strategic investment, CarePredict is well-positioned to accelerate its product development roadmap and expand its footprint in the enterprise health market. The company is expected to focus on deepening its AI capabilities to provide more granular health insights, potentially integrating with broader electronic health record systems to create a seamless continuum of care. Furthermore, the capital will likely support the scaling of its sales and distribution channels, enabling the firm to meet the increasing demand for its technology in both domestic and international markets. As the global population ages, CarePredict's focus on scalable, technology-enabled care solutions remains a cornerstone of its long-term strategic vision.
See full CarePredict company page
